Moreover, it is plausible that PD-L1–mediated activation of p38-MAPK could be synergistic with the activation of conventional tumor-promoting signals like EGF and can be further activated by PD-1 expressed in the tumor-associated microenvironment. This evidence concerns the gene CD274 and neoplasm.